Get started
Author

Emily Powell

Observed name: E Powell
Institution: Parkview Health
ORCID: 0009-0004-6413-1728
Observed ORCID: 0009-0004-6413-1728
OpenAlex ID: A5055419016
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al. · Cancer Research · 8
AML-526: Operational Barriers to Precision Genomic Testing in Hematologic Malignancies: A Qualitative Study
2026 · Summiya Nasim, Kamran Mushtaq, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-526: Operational Barriers to Precision Genomic Testing in Hematologic Malignancies: A Qualitative Study
2026 · Summiya Nasim, Kamran Mushtaq, et al. · Clinical Lymphoma Myeloma & Leukemia
Implementation of a multidisciplinary biomarker care pathway to reduce somatic sequencing failure rates in a community cancer center.
2026 · Emily Powell, Lydia Harman, et al. · Journal of Clinical Oncology
Data from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
Supplementary Figure S11 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
PDF
Supplementary Figure S12 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
PDF
Supplementary Figure S1 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
Supplementary Figure S2 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
Supplementary Figure S10 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
PDF
Supplementary Figure S4 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
Supplementary Figure S5 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
PDF
Supplementary Figure S9 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
PDF
Supplementary Figure S3 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
Supplementary Table S3 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
PDF
Supplementary Figure S6 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
PDF
Supplementary Table S2 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
PDF
Supplementary Table S4 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
Supplementary Table S1 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
Supplementary Figure S7 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
PDF
Supplementary Figure S8 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy
2025 · Amanda L. Rinkenbaugh, Yuan Qi, et al.
PDF
Abstract GS6-06: Identifying metastatic drivers in patient-derived xenograft models of triple negative breast cancer
2018 · E Powell, J Shao, et al. · Cancer Research
Works count: 22
Citation count: 8
H-index: 1
I10-index:
Year
Topic
Type